ClinicalMetric / Countries / Netherlands / cancer
← 🇳🇱 Netherlands Trials
🇳🇱 Netherlands Country × Condition

cancer Clinical Trials in Netherlands

Active clinical trials for cancer with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 Phases: Phase 1 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇳🇱 Netherlands

Active Trials in Netherlands (3)

NCT05062707
Recruiting

Early Ageing During Therapy in AYA Cancer Patients

Enrollment
120 pts
Country
🇳🇱 Netherlands
University Medical Center Groningen
View Trial →
NCT06524570 Phase 1
Recruiting

Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy

Enrollment
24 pts
Country
🇳🇱 Netherlands
UMC Utrecht
View Trial →
NCT07262632
Recruiting

Developing a Multimodal Cancer Pain Database to Support AI-Based Automatic Pain Assessment

Enrollment
200 pts
Country
🇳🇱 Netherlands
Dr. Mark Mulder
View Trial →

Frequently Asked Questions

How many cancer clinical trials are active in Netherlands?
There are currently 3 active clinical trials for cancer with sites in Netherlands, of which 3 are actively recruiting patients.
How can I join a cancer clinical trial in Netherlands?
To join a cancer clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are cancer trials in Netherlands?
Active cancer trials in Netherlands span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Netherlands Trials → Global cancer Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology